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Abstract 
Three methods were developed for simultaneous determination of amlodipine and atorvastatin without previous separation. 
The first method depends on first derivative of the ratios spectra by measurements of the amplitudes at 228 and 245 nm for 
amlodipine using 25 μg/mL of  atorvastatin  as  a  divisor  and  at  284 and 295 nm for  atorvastatin  using  80 μg/mL  of 
amlodipine  as  a  divisor.  Calibration  graphs  were  established  in  the  range  of  10-100  μg/mL  and  2.5-30  μg/mL  for 
amlodipine  and  atorvastatin,  respectively.  The  second  method  describes  the  use  of  multivariate  spectophotometric 
calibration for the simultaneous determination of the analyzed binary mixture, where the resolution is accomplished by 
using partial least squares (PLS) regression analysis. In the third method (HPLC), separation was performed by using C18 
reversed phase column and a mobile phase of acetonitrile: 0.05 M KH2PO4 (60:40v/v) adjusted by phosphoric acid to pH 
3.5 at flow rate of 1 mL/min. All proposed methods were extensively validated and the results obtained by adopting the 
three methods were statistically analyzed and compared with those obtained from a reported method. 
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1. Introduction 
 
Amlodipine (AM) is a long acting calcium 
channel blocker (dihydropyridine class) used as 
antihypertensive and in the treatment of angina. 
Like  other  calcium  channel  blockers, 
amlodipine acts by relaxing the smooth muscle 
in the arterial wall, decreasing total peripheral 
resistance and hence reducing blood pressure; 
in angina it increases blood flow to the heart 
muscle [1]. 
Atorvastatin  (AT)  is  a  second  generation 
HMG-CoA  reductase  inhibitor,  recently 
approved  for  clinical  use  as  a  cholesterol 
lowering  agent.  It  induces  a  significant 
reduction  in  total  cholesterol,  low-density 
lipoprotein cholesterol and plasma triglycerides 
in clinical studies and is also effective for the 
prevention of cardiovascular disease [2-4]. 
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The  chemical  structures  of  the  examined 
drugs are shown in Fig. 1. 
 
 
 
Amlodipine  Atorvastatin 
 
Fig.  1.  Chemical  structures  of  amlodipine  and 
atorvastatin 
 
Literature  survey  revealed  that  HPLC  [5-
11],  HPTLC  [12,  13],  LC-MS  [14],  LC-
MS/MS  [15]  and  simultaneous  UV  – 
spectrophotometric  methods  [16-17]  are 
reported for the estimation of amlodipine alone 
or in combination with other anti-hypertensive 
agents.  Published  analytical  methods  for  the 
quantitative estimation of atorvastatin alone or 
in  combination  with  other  agents  include; 
spectrophotometry [18-20], colorimetry via ion 
pair complexes [21], FT- Raman spectroscopy 
[22],  HPLC  [6,  23-26],  LC-MS  [27,  28], 
HPTLC [29, 30], voltammetric [31], capillary 
electrophoresis [32]. Quantitative spectroscopy 
has  been  greatly  improved  by  the  use  of 
multivariate  statistical  methods  [33-35]. 
Multivariate calibrations are useful in spectral 
analysis because of the simultaneous inclusion 
of  multiple  spectral  intensities  which  can 
greatly improve the precision and applicability 
of quantitative spectral analysis [36]. The aim 
of the present study is to investigate the utility 
of  derivative  ratio  spectrophotometry, 
multivariate methods in addition to a fast and 
sensitive HPLC technique in the assay of AM 
and AT in pharmaceutical preparation without 
the  necessity  of  sample  pre-treatment.  The 
proposed  methods  were  optimized  and 
validated  for  this  purpose.  According  to  the 
ICH description, the developed methods were 
accurate and precise [37]. 
 
2. Experimental 
2. 1. Drug Substances and Dosage Form 
2.  1.  1.  Amlodipine  and  atorvastatin  pure 
substances.  were  kindly  supplied  by  EPICO 
and Novartis Pharma, respectively. 
 
2. 1. 2. Caduet
® Tablets labeled to contain 10 
mg of both drugs, Batch No. 0795049. 
 
2. 2. Reagents 
Acetonitrile  (Fisher  Scientific,  UK). 
Potassium  dihydrogen  phosphate  (KH2PO4)  
(Sigma-Aldrich Chemie, Germany). Orthopho- 
sphoric acid (H3PO4) (Sigma-Aldrich Chemie, 
Germany).  Methanol  (Sigma-Aldrich Chemie, 
Germany). Acetonitrile is HPLC grade and all 
other chemicals are analytical reagent grade. 
 
2. 3. Instrumentation 
Agilent  1200  series  isocratic  quaternary 
pump  HPLC  instrument  connected  to  1200 
multiple  wavelength  UV  detector.  Separation 
was  performed  on  150  x  4.6  mm  Zorbax 
Extend-C18  column  5  µm  particle  size. 
Chromatographic  peaks  were  electronically 
integrated  and  recorded  using  Chemstation 
software (Germany). A Shimadzu (Japan) 1601 
PC  double-beam  UV-visible  spectrophoto-
meter.  PLS  was  modeled  using  PLS  toolbox 
2.0  software  under  MATLAB
®  6.5.  pH/mv 
Meter  with  double  junction  glass  electrode 
(Fisher, USA). 
 
2. 4. Procedure 
2.  4.  1.  Preparation  of  stock  solutions  and 
calibration 
2. 4. 1. 1. For derivative ratio method (DD1) 
Stock solutions of 1 mg/mL AM and 0.05 
mg/mL  AT  were  prepared  in  methanol; 
Aliquots of 0.1 to 1mL AM and 0.5 to 6 mL 
AT  were  transferred  into  10  mL  volumetric 
flasks to reach the concentration ranges of 10-
100  μg/mL
  for amlodipine  and 2.5-30 μg/mL
 
for atorvastatin. According to the theory of the 
ratio- spectra derivative method, the stored UV 
absorption spectra of standard solutions of AM 
were  divide  wavelength-by-wavelength  by  a O. M. Abdallah et al / Int. J. Ind. Chem., Vol. 2, No. 2, 2011, pp. 78-85 
80 
standard spectrum of AT (30 μg/mL). The first 
derivative  was  calculated  for  the  obtained 
spectra with Δλ= 5. The amplitudes at 228 and 
245 nm were measured. For AT, the stored UV 
absorption spectra of standard solutions of AM 
were  divided  wavelength-by-wavelength  by  a 
standard spectrum of amlodipine (80 μg/mL). 
The  first  derivative  was  calculated  for  the 
obtained spectra with Δλ= 5. The amplitudes at 
284 and 295 nm were measured. 
 
2. 4. 1. 2. For multivariate method 
In order to obtain the calibration matrix for 
applying PLS analysis fifteen solutions of each 
of  the  pure  components  (amlodipine  and 
atorvastatin) were prepared in a concentration 
range of 40-80 μg/mL
 and 5-25 μg/mL
 for AM 
and  AT,  respectively.  These  ranges  were 
previously verified to obey Beer's law for each 
of  the  studied  drugs  in  methanol.  The 
absorption  data  in  the  range  of  220-450  nm 
(digitized  every  0.5  nm)  of  15  different 
laboratory  prepared  mixtures  containing 
amounts  of  amlodipine  and  atorvastatin  in 
different  proportions  according  to  the 
multilevel multifactor design were subjected to 
partial least squares analysis in order to obtain 
the  calibration  matrix.  A  Validation  set 
composed  of  7  different  laboratory  prepared 
mixtures containing different concentrations of 
the two drugs were prepared in order to assess 
the  prediction  ability  of  the  proposed  PLS 
method for the analysis of such mixture. 
 
2. 4. 1. 3. For HPLC method 
Amlodipine and atorvastatin stock solutions 
in methanol were prepared by dissolving 10 mg 
of both drugs in 10 mL volumetric flasks (0.1 
μg/mL). Series of working solutions of AM and 
AT were prepared by the appropriate dilution 
of  the  stock  solutions  with  same  solvent  to 
reach the concentration ranges of 10-40 μg/mL
 
for amlodipine and 5-40 μg/mL
 for atorvastatin. 
Triplicate 20 μL injections were made for each 
concentration  using  the  following 
chromatographic conditions: 
Mobile  phase  consisting  of  acetonitrile: 
0.05M  KH2PO4  (60:40  v/v)  adjusted  by 
phosphoric  acid  to  pH  3.5.  Detector 
wavelength: 238 nm for AM and 210 nm for 
AT, flow rate: 1 mL/min, Column temperature: 
ambient temperature (20-22°C).  
Peak area of each concentration was plotted 
against the corresponding concentration for the 
construction of calibration graph. 
 
2. 4. 2. Accuracy Study 
To  study  the  accuracy  of  the  proposed 
methods,  and  to  check  the  interference  from 
excipients present in the dosage form, recovery 
experiments  were  carried  out  by  standard 
addition method. This study was performed by 
addition  of  different  amounts  of  amlodipine 
and  atorvastatin  to  a  known  concentration  of 
the commercial tablets. The resulting mixtures 
were  analyzed  as  described  under  section 
(calibration). 
 
2.  4.  3.  Application  to  Pharmaceutical 
Dosage Form 
Five  tablets  were  powdered.  An  aliquot 
equivalent to one tablet content was accurately 
weighed,  transferred  into  100  mL  volumetric 
flask  containing  about  50  mL  methanol, 
sonicated for 10 min then filtered and diluted to 
volume  with  additional  methanol.  Working 
solutions were prepared by transferring suitable 
aliquots  of  clear  filtrate  and  diluting  with 
appropriate solvent. The assay was completed 
as  under  section  (calibration).  For  the  three 
proposed  methods,  concentrations  of 
amlodipine  and  atorvastatin  were  calculated 
from the corresponding regression equations. 
 
3. Results and Discussion 
3. 1. Optimization of conditions 
3. 1. 1. For DD1 method 
As shown in Fig. 2, the zero-order spectra of 
standard  drugs  were  found  to  be  overlapped 
making  their  simultaneous  determination 
difficult,  ratio-spectra  derivative 
spectrophotometric  method  permits  the 
determination  of  each  component  in  their O. M. Abdallah et al / Int. J. Ind. Chem., Vol. 2, No. 2, 2011, pp. 78-85 
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mixture at the wavelengths corresponding to a 
maximum or minimum. The main advantage of 
DD1  method  is  the  chance  of  easy 
measurements in correspondence to peaks so it 
permits  the use  of  the  wavelength  of  highest 
value  of  analytical  signals  (maximum  or 
minimum). Moreover, the presence of a lot of 
maxima  and  minima  is  another  advantage  by 
the  fact  that  these  wavelengths  give  an 
opportunity  for  the  determination  of  active 
compounds  in  presence  of  other  active 
compounds  or  excipients  which  possibly 
interfere with the analysis. The influence of Δλ 
for  obtaining  the  first  derivative  of  the  ratio 
spectra  as  well  as,  the  effect  of  divisor 
concentration on the calibration graphs for the 
proposed mixture was studied in order to select 
the  best  factors  affecting  the  determination. 
Results indicated that Δλ = 5 nm was the most 
suitable one. 
 
 
Fig. 2. Absorption  spectra  of  amlodipine  (          ), 40 
μg/mL and atorvastatin (----), 20 μg/mL in methanol. 
 
Determination  of  both  drugs  was  done  by 
dividing the absorption spectra of AM by that 
of standard solution of  AT (25 μg/mL) while 
the absorption spectra of AT were divided by 
that of standard solution of  AM  (80  μg/mL). 
The  first  derivative  of  the  developed  ratio 
spectra were calculated with Δλ = 5 nm. Fig. 3, 
shows  that  AM  can  be  determined  by 
measuring  the amplitude at 228 and 245 nm. 
AT  can  be  determined  by  measuring  the 
amplitude  at  284  and  295  nm,  Fig.  4.  The 
proposed  method  is  applicable  over  a 
concentration range of 10-100 μg/mL
 for AM 
and  2.5-30  μg/mL
  for  AT.  The  characteristic 
parameters and necessary statistical data of the 
regression equation, limit of quatitation (LOQ), 
limit  of  detection  (LOD),  repeatability  and 
reproducibility data are collected in Table 1.  
 
 
Fig. 3. First derivative of the ratio spectra of amlodipine 
(10-100  μg/mL).  Divisor  is  30  μg/mL  atorvastatin 
spectrum. 
 
 
Fig. 4. First derivative of the ratio spectra of atorvastatin 
(2.5-30  μg/mL).  Divisor  is  80  μg/mL
  of  amlodipine 
spectrum.  
 
3. 1. 2. For multivariate method 
PLS  method  was  widely  used  for 
simultaneous  determination  of  different  drug 
mixtures in their dosage forms [38-40]. In the 
present study PLS technique is applied for the 
determination of amlodipine and atorvastatin in 
their  binary  mixture.  Mixtures  with  different 
concentrations  of  both  drugs  were  used  as 
calibration samples to construct the model. The 
spectra  of  these  mixtures  were  collected  and 
examined.  The  selection  of  the  optimum O. M. Abdallah et al / Int. J. Ind. Chem., Vol. 2, No. 2, 2011, pp. 78-85 
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number  of  factors  was  a  very  important pre-
construction  step  because  if  the  number  of 
factors retained was more than required more 
noise would be added to the data. On the other 
hand,  if  the  number  retained  was  too  small 
meaningful data that could be necessary for the 
calibration  might  be  discarded.  Different 
methods can be used to determine the optimum 
number of  factors [41, 42].  In this study,  the 
leave–one-out  cross-validation  method  was 
used  and  the  root  mean  square  error  of 
calibration  (RMSEC)  values  of  different 
developed  models  was  compared.  The  model 
selected was that with the smallest number of 
factors such that RMSEC for that model was 
not significantly greater than RMSEC from the 
model with additional factor. As the difference 
between  the  minimum  RMSEC  and  other 
RMSEC values became smaller, the probability 
that  each  additional  factor  was  significant 
became  smaller.  Two  factors  were  found 
suitable, Fig. 5. 
The characteristic parameters and necessary 
statistical data of the regression equation, limit 
of  detection  (LOD),  repeatability  and 
reproducibility data are collected in Table 1.  
Seven  laboratory-prepared  mixtures 
containing different ratios of both drugs were 
subjected  to  the  PLS  analysis  in  order  to 
confirm the suitability of the calibration model 
for  determination  of  studied  drugs  in  the 
pharmaceutical  sample  solutions,  where 
satisfactory results were obtained (Table 2).  
 
 
Fig. 5. RMSEC plot of the cross validation results of the 
training  set  as  a  function  of  number  of  principal 
components used to construct the PLS calibration for AT 
and Am. 
3. 1. 3. For HPLC Method 
In order to perform the simultaneous elution 
of amlodipine and atorvastatin peaks, different 
chromatographic  conditions  were  optimized. 
The  composition  of  the  mobile  phase  was 
studied  by  trying  acetonitrile  and  KH2PO4 
(5x10
-2  M)  in  different  ratios  using  gradient 
elution,  The  best  peak  shape  and  adequate 
separation of the two drugs was obtained by a 
final  composition  of  acetonitrile-KH2PO4 
(60:40 v/v) adjusted by phosphoric acid to pH 
3.5.  
Different flow rates (0.5-1.2 mL/min) were 
tested;  good  resolution  was  obtained  using  1 
mL/min.  Four  wavelengths  were  tried  (210, 
230, 238 and 280 nm); much sensitive detector 
response was obtained at 238 nm for AM and 
210 nm for AT. 
System  suitability  parameters  were 
calculated and the retention times were found 
to be 1.48 min for AM and 2.64 min for AT, 
Fig.  6.  Resolution  and  selectivity  factors  for 
this system were found to be 2.22 and 2.51 for 
AM and AT, respectively. Tailing and capacity 
factors were obtained as 1.21 and 0.91 for AM 
and  1.51  and  1.55  for  AT.  Results  obtained 
from system suitability tests are in agreement 
with the USP requirements.  
 
 
Fig. 6. Representative Chromatogram of amlodipine and 
atorvastatin. 
 
Peak  areas  were  plotted  against 
corresponding  concentrations  in  the  range  of 
10-40 μg/mL for AM and 5-40 μg/mL for AT. 
Linear regression parameters for both drugs in O. M. Abdallah et al / Int. J. Ind. Chem., Vol. 2, No. 2, 2011, pp. 78-85 
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addition  to  LOQ,  LOD  repeatability  and 
reproducibility data are presented in Table 1.  
 
3. 2. Application to Pharmaceutical Dosage 
form 
The  three  proposed  methods  were 
successfully  applied  for  the  simultaneous 
determination of both drugs in Caduet
® tablet 
without  interference  of  the  excipients  present 
and without prior separation. The utility of the 
three  proposed  methods  was  verified  by 
replicate  estimations  of  the  pharmaceutical 
preparation and results obtained are evaluated 
statistically (Table 2). 
 
 
Table 1. Selected Validation Data for the Determination of Amlodipine and Atorvastatin by the Proposed Methods 
 
Parameters 
Amlodipine    Atorvastatin 
DD1 
PLS  HPLC 
DD1 
PLS  HPLC 
λ 228  λ 245  λ 284  λ 295 
Linearity range (μg/mL)  10-100  10-100  40-80  10-40  25-30  25-30  5-25  5-40 
Slope  0.0156  -0.0166  0.9882  24.67  0.0566  -0.0495  1.0124  71.00 
Intercept  0.035  0.0113  0.858  0.094  -0.022  0.0069  -0.207  0.040 
Correlation Coefficient  0.9992  0.9992  0.9990  0.9993  0.9995  0.9999  0.9999  0.9994 
Repeatability (R.S.D %) 
0.22-
0.65 
0.17-
0.55 
0.39-
0.64 
0.27-
0.71 
0.15-
0.36 
0.23-
0.35 
0.31-
0.36 
0.17-
0.28 
Reproducibility (R.S.D % ) 
0.71-
0.93 
0.38-
0.89 
0.71-
0.76 
0.13-
0.54 
0.45-
0.66 
0.63-
0.89 
0.65-
0.89 
0.27-
0.69 
LOQ
* (μg/mL)  3  3  15  4  0.75  0.75  1.5  1.5 
LOD
* (μg/mL)  1  1  5  2  0.25  0.25  0.5  0.75 
 
* LOD and LOQ were estimated based on practical approaches to the proposed methods. For the DD1 and PLS methods, 
they were estimated using linear regression method [37], where LOD = 3Sa/b and LOQ = Sa/b. Where Sa is the standard 
deviation of the response and b is the slope of the calibration curve. For HPLC method LOD and LOQ were determined by 
using the signal-to-noise method [37], a signal-to-noise ratio (S/N) of three is used for estimating LOD and signal-to-noise 
ratio of ten is used for estimating LOQ. 
 
3. 3. Validity of the Proposed Methods 
In  order  to  demonstrate  the  validity  and 
applicability  of  the  proposed  DD1  method, 
recovery studies were performed by analyzing 
laboratory  prepared  mixtures  of  AM  and  AT 
with  different  composition  ratio. The  validity 
of the method was further assessed by applying 
the  standard  addition  technique;  results  are 
presented in Table 2. A statistical comparison 
of the results obtained by the proposed methods 
and the reported HPLC method [6] is shown in 
Table 2. The values of the calculated t and F 
are less than the tabulated ones, which reveals 
that  there  is  no  significant  difference  with 
respect to accuracy and precision between the 
proposed and reported method. 
 
 
4. Conclusions 
The DD1, multivariate calibration technique 
(PLS)  and  HPLC  methods  enable  the 
simultaneous determination of amlodipine and 
atorvastatin in their binary mixture with good 
accuracy  and  precision,  either  in  laboratory 
prepared samples or in combined dosage form. 
HPLC method has the advantage of being more 
sensitive  but  the  spectrophotometric  ones  are 
simpler  and  less  expensive  but  all  of  the 
proposed methods are rapid and selective. The 
good recoveries obtained in all cases as well as 
the  reliable  agreement  with  the  reported 
method  proved  that,  the  proposed  methods 
could  be  applied  efficiently  for  simultaneous 
determination  of  amlodipine  and  atorvastatin 
with quite satisfactory precision and could be 
easily  used  in  quality  control  laboratory  for O. M. Abdallah et al / Int. J. Ind. Chem., Vol. 2, No. 2, 2011, pp. 78-85 
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their analysis. The proposed HPLC method is 
very  comparable  to  the  reported  HPLC  one 
regarding  retention  times  and  limit  of 
quantitation of both drugs. In addition to that, 
the  C18  column  used  in  the  proposed  HPLC 
method is more preferred than that used in the 
reported HPLC method due its availability and 
lower cost.  
 
 
Table 2. Determination of AM and AT in Authentic, laboratory Prepared Mixtures and Pharmaceutical Dosage Form 
Using DD1, PLS, HPLC and Reported Method [6]. 
 
HPLC  PLS  DD1 
Reported*  Analyzed Solution 
    λ 245  λ 228 
99.38±1.36  100.01±1.06  99.32±1.09  99.35±0.86  100.13±1.24  Authentic AM 
5  15  5  3  5  N 
1.04(1.83)**  0.21 (1.73)**  1.18(1.83)**  1.02(1.89)**  -  t 
1.20(5.05)**  1.36 (4.62)**  1.29(5.05)**  2.07(9.01)**  -  F 
    λ 295  λ 284 
100.25±0.84  Authentic AT  99.94±1.18  100.01±1.49  99.77±0.66  99.23±1.48 
7  15  6  4  5  N 
0.51 (1.83)**  1.09 (1.73)**  0.92(1.81)**  1.43(1.86)**  -  t 
1.97 (4.88)**  3.14 (4.62)**  1.61(4.39)**  3.10(5.19)**  -  F 
99.75±0.98  98.86±1.48  99.68±0.39  99.72±0.64  -  AM in laboratory prepared mix. 
99.50±0.88  98.80 ±2.55  100.31±0.31  99.76±0.36  -  AT in laboratory prepared mix. 
99.39±0.34  99.92±0.87  99.82±0.61  99.53± 0.52  -  AM in Caduet® tablet 
99.61±0.20  99.80±0.72  100.12±0.72  99.73±0.61  -  AT in Caduet® tablet 
100.57±0.58  99.87±0.72  99.83±0.67  100.19± 0.60  -  Standard addition technique for Am 
99.31±0.15  99.88±0.75  100.12±0.63  100.21±0.81  -  Standard addition technique for AT 
 
* Reported method used is an isocratic reversed-phase stability-indicating HPLC assay for the simultaneous determination 
of AT and AM in commercial tablets. Separation was achieved on a Perfectsil
® Target ODS-3, 5 μm, 250 mm × 4.6 mm 
i.d. column using a mobile phase consisting of acetonitrile–0.025 M NaH2PO4 buffer (pH 4.5) (55:45, v/v) at a flow rate of 
1 mL/min and UV detection at 237 nm. Retention times  were 1.55 min for AM and 3.32 min for AT. The limits  of 
quantitation were 2 μg/mL and 1 μg/mL for AM and AT, respectively. 
 
** Theoretical values at 95% confidence limit 
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